ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

330
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
17 Aug 2020 09:14

Who Will Buy SamE Stake Potentially Sold by Samsung Life? Samsung C&T or SamE?

Samsung C&T is one of the most likely candidates to purchase additional stakes in Samsung Electronics. One of the strategies that Samsung...

Logo
257 Views
Share
16 Aug 2020 07:37

Asia Short Interest Weekly: AliHealth, Meituan, SunnyOptical, WuXi Apptec, Canon, Lasertec, Seegene

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
309 Views
Share
bullishWuxi Biologics
16 Jul 2020 10:21

Wuxi Biologics - Recap/Learnings from past Placements

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
481 Views
Share
02 Jul 2020 00:03

Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing

Local institutions in Korea will have a significant underperformance on SK Biopharm listing and will clamor to buy and makeup for their...

Logo
359 Views
Share
bullishWuxi Biologics
29 Jun 2020 18:42

Wuxi Biologics Placement - This Time It's Different

Wuxi Biologics (Cayman) Inc (2269 HK) is looking to raise around US$660m in a primary placement. This is in contrast to the nine other placement...

Logo
456 Views
Share
x